vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and BankUnited, Inc. (BKU). Click either name above to swap in a different company.
BankUnited, Inc. is the larger business by last-quarter revenue ($288.2M vs $268.1M, roughly 1.1× ACADIA PHARMACEUTICALS INC). On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs 9.0%). Over the past eight quarters, BankUnited, Inc.'s revenue compounded faster (9.2% CAGR vs 5.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
BankUnited, Inc. is the bank holding company of BankUnited, N.A., a national bank founded in 1984 and headquartered in Miami Lakes, Florida. The company operates in Florida; the regions in and around Atlanta, Georgia; Dallas, Texas; Morristown, New Jersey; Charlotte, North Carolina; and in the New York metropolitan area. BankUnited also offers certain commercial lending and deposit products through national platforms and has total assets of $35.0 billion as of December 31, 2025
ACAD vs BKU — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $288.2M |
| Net Profit | $3.6M | — |
| Gross Margin | — | — |
| Operating Margin | -1.7% | 31.2% |
| Net Margin | 1.4% | — |
| Revenue YoY | 9.7% | 9.0% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.02 | $0.89 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | — | ||
| Q4 25 | $284.0M | $288.2M | ||
| Q3 25 | $278.6M | $275.7M | ||
| Q2 25 | $264.6M | $273.9M | ||
| Q1 25 | $244.3M | $255.4M | ||
| Q4 24 | $259.6M | $264.5M | ||
| Q3 24 | $250.4M | $257.0M | ||
| Q2 24 | $242.0M | $250.2M |
| Q1 26 | $3.6M | — | ||
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | $71.9M | ||
| Q2 25 | $26.7M | $68.8M | ||
| Q1 25 | $19.0M | $58.5M | ||
| Q4 24 | $143.7M | — | ||
| Q3 24 | $32.8M | $61.5M | ||
| Q2 24 | $33.4M | $53.7M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | -1.7% | — | ||
| Q4 25 | 6.1% | 31.2% | ||
| Q3 25 | 12.8% | 35.5% | ||
| Q2 25 | 12.2% | 34.3% | ||
| Q1 25 | 7.9% | 31.4% | ||
| Q4 24 | 59.1% | 35.2% | ||
| Q3 24 | 12.6% | 32.4% | ||
| Q2 24 | 12.6% | 29.2% |
| Q1 26 | 1.4% | — | ||
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | 26.1% | ||
| Q2 25 | 10.1% | 25.1% | ||
| Q1 25 | 7.8% | 22.9% | ||
| Q4 24 | 55.4% | — | ||
| Q3 24 | 13.1% | 23.9% | ||
| Q2 24 | 13.8% | 21.5% |
| Q1 26 | $0.02 | — | ||
| Q4 25 | $1.61 | $0.89 | ||
| Q3 25 | $0.42 | $0.95 | ||
| Q2 25 | $0.16 | $0.91 | ||
| Q1 25 | $0.11 | $0.78 | ||
| Q4 24 | $0.86 | $0.91 | ||
| Q3 24 | $0.20 | $0.81 | ||
| Q2 24 | $0.20 | $0.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $217.8M |
| Total DebtLower is stronger | — | $319.7M |
| Stockholders' EquityBook value | — | $3.1B |
| Total Assets | $1.6B | $35.0B |
| Debt / EquityLower = less leverage | — | 0.10× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $177.7M | $217.8M | ||
| Q3 25 | $258.0M | $559.5M | ||
| Q2 25 | $253.6M | $801.3M | ||
| Q1 25 | $217.7M | $443.7M | ||
| Q4 24 | $319.6M | $491.1M | ||
| Q3 24 | $155.1M | $889.9M | ||
| Q2 24 | $177.1M | $433.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $319.7M | ||
| Q3 25 | — | $320.4M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $709.1M | ||
| Q4 24 | — | $708.6M | ||
| Q3 24 | — | $708.7M | ||
| Q2 24 | — | $708.8M |
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $3.1B | ||
| Q3 25 | $917.3M | $3.0B | ||
| Q2 25 | $822.4M | $3.0B | ||
| Q1 25 | $765.2M | $2.9B | ||
| Q4 24 | $732.8M | $2.8B | ||
| Q3 24 | $577.2M | $2.8B | ||
| Q2 24 | $516.7M | $2.7B |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $35.0B | ||
| Q3 25 | $1.3B | $35.1B | ||
| Q2 25 | $1.2B | $35.5B | ||
| Q1 25 | $1.1B | $34.8B | ||
| Q4 24 | $1.2B | $35.2B | ||
| Q3 24 | $976.9M | $35.8B | ||
| Q2 24 | $914.1M | $35.4B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 0.11× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | 0.25× | ||
| Q2 24 | — | 0.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $358.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-48.7M | $358.6M | ||
| Q3 25 | $74.3M | $99.7M | ||
| Q2 25 | $64.0M | $117.6M | ||
| Q1 25 | $20.3M | $16.4M | ||
| Q4 24 | $40.4M | $433.8M | ||
| Q3 24 | $63.2M | $46.1M | ||
| Q2 24 | $25.0M | $135.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $63.2M | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | 1.39× | ||
| Q2 25 | 2.40× | 1.71× | ||
| Q1 25 | 1.07× | 0.28× | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | 0.75× | ||
| Q2 24 | 0.75× | 2.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
